Late Stage Rescue Proven ability to salvage at-risk Phase Three studies and maintain regulatory timelines, with capabilities in sNDA/sBLA submissions.

US Based Advantage Fully USA-based with a Boston area footprint and senior staff directly managing projects, appealing to sponsors prioritizing domestic operations, data security, and regulatory familiarity.

Regulatory Expertise Deep regulatory services spanning sNDA/sBLA submissions, ISS, ISE, HTA, eCRT, FDA IR, and legacy to CDISC migrations, enabling end-to-end submission readiness.

Experienced Team Team comprises seasoned biostatisticians and programmers with deep pharmaceutical experience, many with PhDs, most holding MS degrees or higher, and very low turnover, enabling reliable analyses and timely delivery.

Flexible Engagement Project-based and unit-based service model with a flat reporting structure; referrals drive most new work; senior staff serve as project managers, delivering lean oversight and cost-effective timing.